Antigen News and Research

RSS
Surgical treatment unnecessary for many prostate cancer patients

Surgical treatment unnecessary for many prostate cancer patients

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

Whole-body imaging PET/MRI offers information to guide treatment options for prostate cancer

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Lund University researchers succeed in obtaining dendritic cells by direct reprogramming

Lund University researchers succeed in obtaining dendritic cells by direct reprogramming

Men with inflammatory bowel disease have higher prostate cancer risk

Men with inflammatory bowel disease have higher prostate cancer risk

Acutely injured deceased-donor kidneys are suitable for transplant, study suggests

Acutely injured deceased-donor kidneys are suitable for transplant, study suggests

UAB research may point a path to more effective influenza vaccines

UAB research may point a path to more effective influenza vaccines

New study confirms effectiveness of PSA screening in reducing prostate cancer deaths

New study confirms effectiveness of PSA screening in reducing prostate cancer deaths

From Our Bench to Yours: Antibody Advice from Proteintech

From Our Bench to Yours: Antibody Advice from Proteintech

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Physician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Maryland researchers receive grant to study the brain-to-gut connection in schizophrenia

Maryland researchers receive grant to study the brain-to-gut connection in schizophrenia

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Study: 39% of B cell lymphoma patients treated with CAR T therapy remain in remission

Scientists use genetically engineered immune cells to fight Hodgkin and non-Hodgkin lymphoma cells

Scientists use genetically engineered immune cells to fight Hodgkin and non-Hodgkin lymphoma cells

New strategies may improve performance of CAR-T cell therapy in treating cancer

New strategies may improve performance of CAR-T cell therapy in treating cancer

Study shows outcomes of CAR T-cell therapy when used as standard of care for lymphoma

Study shows outcomes of CAR T-cell therapy when used as standard of care for lymphoma

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

SSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Study: 51% of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma

Study: 51% of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

The Native Antigen Company launches ground-breaking Zika virus immunoassays

The Native Antigen Company launches ground-breaking Zika virus immunoassays

Antibodies: A Stable and Specific way to Target Cells in the Nervous System

Antibodies: A Stable and Specific way to Target Cells in the Nervous System